A leukemia survivor recalls how bonding with other patients helped his hospital stays go by faster and became a key part of his emotional healing.
|Videos|October 9, 2018
A Message From Amy Robach on Breast Cancer Awareness Month
Author(s)Amy Robach
Share your cancer story, says news anchor and survivor Amy Robach.
Advertisement
One of the most powerful things that patients with breast cancer can do is share their story, explained news anchor and breast cancer survivor Amy Robach.
Robach shared her own story when she had a mammogram on live television with millions of people watching. She ended up being diagnosed with breast cancer after that, and continues to be vocal about her experiences.
If you are interested in sharing your story with the CURE audience, visit
Advertisement
Related to this article
Learn how nipple-sparing mastectomy, including endoscopic approaches, may help preserve appearance, reduce scarring and support breast cancer recovery.
After 17 and a half years with metastatic primary peritoneal cancer, a former hospital executive explains how an AI health agent helped her after discharge.
Giredestrant plus Afinitor lowered the risk of cancer worsening or death by 62% in patients with ESR1-mutated, ER-positive, HER2-negative advanced breast cancer.
A study of more than 17,000 patients ages 23 to 64, presented at ASTRO 2026, found that only about 28% took endocrine therapy consistently for five years, and people who skipped radiation were more likely to fall off. Here's what to weigh before making that choice.
September brought new options for breast, lung, kidney, bile duct, skin and neuroendocrine cancers, plus a brain tumor scan and easier lung cancer treatment.
Breast cancer treatment has changed dramatically since 2021. Here are the key FDA approvals, year by year, and what they mean for patients.
Learn how to cope with life after cancer treatment with Dr. Eric Bengtsen, a psycho-oncology psychiatrist at Memorial Sloan Kettering Cancer Center.
Advertisement
Advertisement
Trending on CURE
1
5 Years of Breast Cancer Advances: A Timeline of FDA Approvals and What They Mean for Patients
2
Phase 3 Trial Shows Adding Imdelltra to First-Line Treatment Helps Patients With SCLC Live Longer
3
Six Years Later, Most Myeloma Patients on a Darzalex Regimen Are Still Progression-Free
4
10 Cancer Treatment Approvals From September 2026 and What They Mean for You
5